Category Archives: Pulmonology

Greer v. The Lancet 4:23-cv-03761 S.D.T.X.

October 1, 2023- by Steven E. Greer, MD

Posted in - Opinion, CDC, CMS, Congress, FDA, Infectious disease, NIH, Pulmonology | Leave a comment

Rudy Giuliani interviews Steven E. Greer, MD on his podcast TV show: May 15, 2020

May 15, 2020

Posted in - Opinion, - Policy, Emergency medicine, Geriatrics, Infectious disease, Internal Medicine, Pulmonology | Leave a comment

Steven E. Greer, MD on OANN discussing virus therapies

April 16, 2020

Posted in - Biotech, - Generics, - Opinion, - Pharma, CDC, CMS, Congress, Emergency medicine, FDA, Geriatrics, Infectious disease, Internal Medicine, NIH, Pediatrics, Primary care medicine, Pulmonology, VA | Leave a comment

Joe Piscopo interviews Steven E. Greer, MD: 5-22-2020

May 22, 2020

Posted in - Biotech, - Generics, - Opinion, - Pharma, - Policy, Emergency medicine, Infectious disease, Pulmonology | Leave a comment

WABC radio morning show Bernie & Sid interviews Steven E. Greer, MD: May 21, 2020

May 21, 2020- by Steven E. Greer, MD In this segment,

Posted in - Opinion, - Pharma, - Policy, Emergency medicine, Infectious disease, Internal Medicine, Pulmonology | Leave a comment

How to beat the virus with early treatment

July 22, 2021- by Steven E. Greer, MD I woke up yesterday with a slight malaise and I sneezed once. I knew I had come down with a virus

Posted in - Biotech, - Generics, - Opinion, - Pharma, - Policy, Duke, Emergency medicine, Geriatrics, Infectious disease, Internal Medicine, Pediatrics, Primary care medicine, Pulmonology | Leave a comment

The only thing we have to fear…is fear itself

March 13, 2020- by Steven E. Greer, MD Holy cow. The PGA Tour cancelled the Players Championship due to fears over the coronavirus.

Posted in - Biotech, - Medical Devices, - Opinion, - Pharma, - Policy, CDC, CMS, Congress, Emergency medicine, FDA, Infectious disease, Internal Medicine, NIH, Primary care medicine, Pulmonology, VA | Leave a comment

The human population has already reached the herd immunity state for The Wuhan virus

July 23, 2020- by Steven E. Greer, MD As the propagandists in the mainstream media continue their full-court-press of fearmongering,

Posted in - Policy, Emergency medicine, Infectious disease, Internal Medicine, Primary care medicine, Pulmonology | Leave a comment

Far-left NeverTrump propaganda has hijacked the peer-review process

June 3, 2020- by Steven E. Greer, MD We are living

Posted in - JAMA, - NEJM, - Opinion, - Pharma, - Policy, Emergency medicine, Infectious disease, Internal Medicine, Pulmonology | 3 Comments

The “surge in new Wuhan virus cases” is great news

June 26, 2020- by Steven E. Greer, MD I called it, once again. On June 9th, I wrote, “This unprecedented communist-party-like anarchy in

Posted in - Biotech, - Opinion, - Pharma, - Policy, Emergency medicine, Infectious disease, Internal Medicine, Pediatrics, Primary care medicine, Pulmonology | 2 Comments

How infectious and lethal is this Coronavirus COVID-19 compared to regular “flu”?

February 28, 2020- by Steven E. Greer, MD Just published online in the NEJM is a report with the death rates in China

Posted in - NEJM, CDC, Congress, FDA, Infectious disease, Internal Medicine, NIH, Pediatrics, Primary care medicine, Pulmonology | Leave a comment

Anthony Fauci unjustifiably caused a mass panic

March 13, 2020- by Steven E. Greer, MD With one sentence in response to a question from a congressional hearing, an obscure medical

Posted in - Policy, CDC, CMS, Congress, Infectious disease, Internal Medicine, NIH, Primary care medicine, Pulmonology | Leave a comment

Triple Therapy for Cystic Fibrosis

October 18, 2018- interviewed by Steven E. Greer, MD

Posted in - Biotech, - NEJM, - Pharma, FDA, Genetics, Infectious disease, Internal Medicine, National Jewish Health, Pediatrics, Pulmonology | Leave a comment

KIT inhibition by Gleevec (imatinib) for severe asthma

May 26, 2017- Interviewed by Steven E. Greer, MD Novartis’ Gleevec (imatinib) was approved in the U.S. in 2001 to treat leukemia. Now, researchers

Posted in - Biotech, - NEJM, - Pharma, National Jewish Health, Pulmonology | Leave a comment

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

May 23, 2017- interviewed by Steven E. Greer, MD We interviewed polumonologist Michael Wechsler, MD about his paper in the NEJM testing mepolizumab

Posted in - NEJM, National Jewish Health, Pulmonology, Rheumatology | Leave a comment